Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Leslie B. Tyson"'
Autor:
Lee M. Krug, Maria Catherine Pietanza, Naoko Takebe, Rosalyn A. Juergens, Mark G. Kris, Sara Subzwari, Naiyer A. Rizvi, Andrew Brown, William D. Travis, Paul K. Paik, Leonard James, Charles M. Rudin, Michelle S. Ginsberg, Susan Markus, Leslie B. Tyson
Publikováno v:
Lung Cancer. 74:481-485
We previously reported data on the safety, tolerability, and recommended phase II dose of obatoclax mesylate in conjunction with topotecan in patients with advanced solid tumor malignancies. Preliminary efficacy data suggested activity in patients wi
Publikováno v:
Clinical Journal of Oncology Nursing. 12:341-352
Despite the common occurrence of cancer-related dyspnea, a paucity of literature is available for review, especially research literature that reports interventions to control dyspnea. The Oncology Nursing Society’s Putting Evidence Into Practice®
Autor:
Lee M. Krug, Barbara Coleman, Barbara Pizzo, Lauren Lastinger, Teresa Seeger, Christopher G. Azzoli, Amy Farmer, Charles M. Rudin, Mark G. Kris, Erin Moore, Naiyer A. Rizvi, Vincent A. Miller, Leslie B. Tyson, Ennapadam Venkatraman, Megan Dunne
Publikováno v:
Journal of Thoracic Oncology. 2(7):638-644
Introduction We undertook this phase II study to measure postoperative drug delivery and toxicity of cisplatin plus docetaxel in patients with resected stage I-III non-small cell lung cancer. Methods The primary endpoint was amount of cisplatin deliv
Autor:
Jeffrey S. Ross, Mark G. Kris, Barbara Pizzo, Leslie B. Tyson, Christopher G. Azzoli, Christine E. Sheehan, John P. Crapanzano, Vincent A. Miller, Lee M. Krug, Ennapadam Venkatraman, Jyoti D. Patel, Robert T. Heelan, Jorge Gomez
Publikováno v:
Cancer. 104:2149-2155
BACKGROUND Trastuzumab is a monoclonal antibody directed against the human epidermal growth factor receptor-2 (HER-2). Nonsmall cell lung carcinoma (NSCLC) overexpresses HER-2 protein in approximately 20% of cases. In the current study, the authors c
Autor:
William Pao, Vincent A. Miller, Murk-Hein Heinemann, Mark G. Kris, Barbara Pizzo, Dana L. Sachs, Leah Ben-Porat, Leslie B. Tyson, Robert T. Heelan, Neelam T. Shah
Publikováno v:
Journal of Clinical Oncology. 23:165-174
Purpose The use of gefitinib, the first drug approved to inhibit the epidermal growth factor receptor tyrosine kinase, is indicated in patients with non–small-cell lung cancer with tumors progressive after chemotherapy. The unique mechanism of acti
Publikováno v:
Clinical Journal of Oncology Nursing. 8:645-652
Autor:
Barbara Pizzo, Manreen Zakowski, Ennapadam Venkatraman, Lee M. Krug, William Pao, Valerie W. Rusch, Vincent A. Miller, Natalie Memoli, Jyoti D. Patel, Naiyer A. Rizvi, Leslie B. Tyson, Christopher G. Azzoli, Mark G. Kris, Neelain Shah, Jorge Gomez, Robert T. Heelan, Leah Ben-Porat
Publikováno v:
Journal of Clinical Oncology. 22:1103-1109
Purpose Gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, induces radiographic regressions and symptomatic improvement in patients with non–small-cell lung cancer (NSCLC). Phase II trials suggested female sex and aden
Autor:
Binsheng Zhao, Camelia S. Sima, Kai Hsiung Lin, Dyana K. Sumner, Michelle S. Ginsberg, Lauren J. Rogak, M. Catherine Pietanza, Alison Berkowitz-Hergianto, Marwan Shouery, Samantha Lindsay Kass, Mark G. Kris, Ethan Basch, Aaron Gabow, Mary Shaw, Lawrence H. Schwartz, Alex E. Lash, Manda Wilson, Marcia Latif, Leslie B. Tyson, Qinfei Wu, Claire Miller
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(16)
Purpose In clinical trials, traditional monitoring methods, paper documentation, and outdated collection systems lead to inaccuracies of study information and inefficiencies in the process. Integrated electronic systems offer an opportunity to collec
Autor:
Lorraine Baltzer Cleri, Leslie B. Tyson, Rebecca A. Clark, Katherine M.W. Pisters, Richard J. Gralla, Mark G. Kris
Publikováno v:
Cancer. 76:774-778
Background. Intravenous antiemetic combinations containing a 5-HT3 receptor antagonist (like metoclopramide, ondansetron, or granisetron) with dexamethasone have become the standard therapy for the treatment of acute chemotherapy-induced vomiting. In
Autor:
Leslie B, Tyson
Publikováno v:
ONS connect. 27(2)